eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » BIO - Testimony

BIO - Testimony

Document ID: FDA-2011-N-0326-0028
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: December 22 2011, at 12:00 AM Eastern Standard Time
Date Posted: January 11 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: December 7 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: January 6 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80f88292
View Document:  View as format xml

View Comment

Public Submission

Attachments:

2012-12-16 BIO BsUFA Slides

Title:
2012-12-16 BIO BsUFA Slides

View Attachment: View as format pdf

Related Comments

    View All
Total: 12
Academy of Managed Care Pharmacy (AMCP) - Comment
Public Submission    Posted: 01/11/2012     ID: FDA-2011-N-0326-0026

Jan 06,2012 11:59 PM ET
Shein-Chung Chow, PhD Duke University School of Medicine - Testimony
Public Submission    Posted: 01/11/2012     ID: FDA-2011-N-0326-0027

Jan 06,2012 11:59 PM ET
BIO - Testimony
Public Submission    Posted: 01/11/2012     ID: FDA-2011-N-0326-0028

Jan 06,2012 11:59 PM ET
Pfizer Inc - Comment
Public Submission    Posted: 01/11/2012     ID: FDA-2011-N-0326-0032

Jan 06,2012 11:59 PM ET
AARP - Comment
Public Submission    Posted: 01/11/2012     ID: FDA-2011-N-0326-0034

Jan 06,2012 11:59 PM ET